Ayşe Serap KARADAĞ, Derun Taner ERTUĞRUL, Emre TUTAL, Kadir Okhan AKIN

The role of anemia and vitamin D levels in acute and chronic telogen effluvium

Telogen effluvium (TE) is an abnormality of hair cycling. Vitamin D promotes hair follicle differentiation. The importance of vitamin D in hair growth is evident in patients with hereditary vitamin D receptor deficiency. The role of vitamin D in the pathogenesis of TE has not been investigated before. We investigated the role of vitamin D, ferritin, and zinc in the pathogenesis of TE. Materials and methods: We measured serum hemoglobin, ferritin, zinc, calcium, phosphate, parathormone, magnesium, 25 and 1,25-hydroxyvitamin D3, and bone alkaline phosphatase and thyroid stimulating hormone levels in 63 female patients and 50 control subjects. Twenty-nine of the TE patients were classified in the acute TE group and 34 were classified in the chronic TE groups. Results: Ferritin (acute TE; 17.0 ± 12.8, chronic TE; 19.6 ± 15.2, control; 35.5 ± 31.8, P < 0.001) and hemoglobin (acute TE; 12.7 ± 1.7, chronic TE; 13.3 ± 1.0, control; 14.2 ± 1.2, P < 0.0001) levels were significantly lower in the TE group than in the control group. However, 25-hydroxyvitamin D3 levels were significantly higher in the TE group than in the control group (acute TE; 18.5 ± 9.2, chronic TE; 24.4 ± 11.2, control; 15.6 ± 15.8, P < 0.01). Vitamin D levels increased gradually from control groups to acute and chronic TE groups. However, active D vitamin levels (1,25-hydroxyvitamin D3) were similar. Conclusion: Iron deficiency anemia seems to be the main triggering factor for the development of TE and the increase in serum 25-hydroxyvitamin D3 levels may be related to increased exposure to UV light due to TE.

Anahtar Kelimeler:

Key words: Alopecia, hair disorder, telogen effluvium, vitamin D

The role of anemia and vitamin D levels in acute and chronic telogen effluvium

Keywords:

Key words: Alopecia, hair disorder, telogen effluvium, vitamin D,

PDF

___

Harrison S, Sinclair R. Telogen effl uvium. Clin Exp Dermatol 2002; 27: 389-95. 2. Kligman A. Pathologic dynamics of human hair loss. I. Telogen effl uvium. Arch Dermatol 1961; 83: 175-98.
Dawber RPR, Simpson NB, Barth J. Diff use alopecia: endocrine, metabolic and chemical infl uences on the follicular cycle. In: Dawber RPR, eds. Diseases of the hair and scalp. 3rd ed. Oxford: Blackwell Science; 1997. p.123-50.
Scoggins RB, Harlan WR. Cutaneous manifestations of hyperlipidaemia and uraemia. Postgrad Med 1967; 41: 357-8. 5. Headington JT. Telogen effl uvium. New concepts and review. Arch Dermatol 1993; 129: 356-63. 6. Whiting DA. Chronic telogen effl uvium: increased scalp hair shedding in middle aged women. J Am Acad Dermatol 1996; 35: 899-906. 7. Sinclair R. Th ere is no clear association between low serum ferritin and chronic diff use telogen hair loss. Br J Dermatol 2002; 147: 982-4.
Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol 2007; 16: 618-25.
Zlotogorski A, Hochberg Z, Mirmirani P, Metzker A, Ben- Amitai D, Martinez-Mir A, et al. Clinical and pathologic correlations in genetically distinct forms of atrichia. Arch Dermatol 2003; 139: 1591-6.
Vegesna V, O’Kelly J, Uskokovic, M, Said J, Lemp N, Saitoh T et al. Vitamin D3 analogs stimulate hair growth in nude mice. Endocrinology 2002; 143: 4389-96.
Gautam CS, Saha L, Sekhri K, Saha PK. Iron defi ciency in pregnancy and the rationality of iron supplements prescribed during pregnancy. Medscape J Med 2008; 10: 283.
Trost LB, Bergfeld WF, Calogeras E. Th e diagnosis and treatment of iron defi ciency and its potential relationship to hair loss. J Am Acad Dermatol 2006; 54: 824-44.
Olsen EA. Iron defi ciency and hair loss: the jury is still out. J Am Acad Dermatol 2006; 54: 903-6.
Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121: 985-8.
Sinclair RD. Diff use hair loss. Int J Dermatol 1999; 38: 8-18.
Olsen EA. Th e midline part: An important physical clue to the diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 1999; 40: 106-9.
Shrivastava SB. Diff use hair loss in an adult female: Approach to diagnosis and management. Indian J Dermatol Venereol Leprol 2009; 75: 20-8.
Deloche C, Bastien P, Chadoutaud S, Galan P, Bertrais S, Hercberg S et al. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol 2007; 17: 507- 12.
Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol 2002; 27: 396-404.
Bregy A, Trueb RM. No association between serum ferritin levels >10 microg/l and hair loss activity in women. Dermatology 2008; 217: 1-6.
Rushton DH, Ramsey ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of diff use alopecia in women. Br J Dermatol 1990; 123: 187-97.
Alhaj E, Alhaj N, Alhaj NE. Diff use alopecia in a child due to dietary zinc defi ciency. Skinmed 2007; 6: 199-200.
Ead RD. Oral zinc sulphate in alopecia areata – a double blind study. Br J Dermatol 1981; 104: 483-4.
Arnaud J, Beani JC, Favier AE, Amblard P. Zinc status in patients with telogen defl uvium. Acta Derm Venereol (Stockh) 1995; 75: 248-9.
Clemens TL, Adams JS, Horiuchi N, Gilchrest BA, Cho H, Tsuchiya Y et al. Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fi broblasts from skin of normal subjects and a subject with vitamin-D dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 1983; 56: 824-30.
Ramot Y, Paus R, Tiede S, Zlotogorski A. Endocrine controls of keratin expression. BioEssays 2009; 31: 389-99.
Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001; 98: 7498-503.
Slominski A, Paus R, Costantino R. Diff erential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol 1991; 96: 172-9.